Identification of neural correlates of relapse to alcohol after treatment is clinically important as it may inform better substance abuse treatment. Few studies have specifically analyzed the white matter microstructure in treatment seekers as it might relate to relapse risk versus long-term abstinence. Using 4 Tesla diffusion tensor imaging, we compared two groups of one-month-abstinent treatment-seekers, who were classified based on their drinking status between six and nine months after treatment initiation. We hypothesized that subsequent relapsers had greater white matter microstructural deficits in specific brain regions than long-term abstainers. At one month of abstinence, 37 future relapsers versus 25 future abstainers had lower fractional anisotropy (a measure of axonal organization and membrane integrity) in the corpus callosum and right stria terminalis/ fornix, higher diffusivity in the genu of the corpus callosum, left and right stria terminalis/fornix, and lower diffusivity in left anterior corona radiata. These differences existed despite similar lifetime and recent drinking and smoking histories in the groups. Longer smoking duration in relapsers was associated with lower fractional anisotropy in right stria terminalis/fornix. The study identified specific microstructural biomarkers of alcohol relapse risk in adults, contributing to the definition of a neurobiological relapse risk profile in alcohol use disorder.
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Introduction
Alcohol use disorder (AUD) is associated with a chronically relapsing-remitting course over lifetime (Witkiewitz and Marlatt, 2007) . Most individuals treated for AUD will relapse to hazardous alcohol consumption within just six months of treatment (Kirshenbaum et al., 2009; Meyerhoff and Durazzo, 2010; Witkiewitz, 2011) . Resumption to hazardous drinking for long periods relates to clinically significant impairments of psychosocial functioning (e.g., unemployment, relationship/marital discord, legal entanglements) and maintains cognitive dysfunction in AUD (Durazzo et al., 2008; Maisto et al., 2006 Maisto et al., , 2007 . On the other hand, sustained abstinence following treatment relates to significant improvements in neurocognitive and adaptive psychosocial functioning (e.g., Pennington et al., 2013 and references cited therein) and to at least partial recovery from prefrontal neurobiological injury thought to be related to previous chronic heavy alcohol use (for reviews see Buhler and Mann, 2011; Xiao et al., 2015; Zahr, 2014) .
Various neuroimaging modalities have been employed to characterize brain changes with chronic alcohol consumption and to identify potential imaging biomarkers of increased relapse risk after AUD treatment (e.g., Meyerhoff and Durazzo, 2010; Meyerhoff et al., 2013; Seo and Sinha, 2014, 2015;  for review see Moeller and Paulus, 2018) . Brain biomarkers measured either alone or together with other markers often provide better predictions of treatment outcomes than measures of for example education, neurocognition, craving, stress or psychiatric symptomatology (e.g., Volkow and Baler, 2013; Gabrieli et al., 2015) . Identification of specific neural correlates of relapse are therefore clinically important as it may inform better substance abuse treatment and predict long-term clinical outcomes. 
